REQUEST A DEMO
Total
USD $0.00
Search more companies

Kurtsan Medikal A.S. (Turkiye)

Main Activities: Surgical and Medical Instrument Manufacturing
Full name: Kurtsan Medikal Sanayi Ve Ticaret Anonim Sirketi Profile Updated: August 01, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Kurtsan Holding operates in the personal care and pharmaceutical industries, offering products in categories such as hair, skin, and body care, as well as dermatology, otorhinolaryngology, orthopedics, physiotherapy, and pediatrics. They have a wide sales channel coverage and work with pharmaceutical and medical distributors, hospitals, and B2C channels. Kurtsan Holding is known for developing pharmaceuticals, remedies, and cosmetics from plants in Anatolia. They have obtained certifications for their manufacturing processes and have obtained three patents in the Turkish pharmaceutical industry. Kurtsan Holding operates through subsidiaries such as Kurtsan Holding Pharmaceuticals Inc. and Kurtsan Holding Medical Inc.

Headquarters
Daire:4 No:14c Merkez Mahallesi Baglar Caddesi Kagithane
Istanbul; Marmara; Postal Code: 34406

Contact Details: Purchase the Kurtsan Medikal A.S. report to view the information.

Website: http://www.kurtsan.com

Basic Information
Total Employees:
Purchase the Kurtsan Medikal A.S. report to view the information.
Outstanding Shares:
Purchase the Kurtsan Medikal A.S. report to view the information.
Incorporation Date:
February 18, 1988
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Kurtsan Medikal A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
10.81%
Total operating revenue
10.81%
Operating profit (EBIT)
-45.63%
Net Profit (Loss) for the Period
-41.6%
Total assets
23.63%
Total equity
30.87%
Operating Profit Margin (ROS)
-9.65%
Net Profit Margin
-6.74%
Return on Equity (ROE)
-25.36%
Quick Ratio
0.26%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?